Qingjia Chi

1.9k citations
66 papers · 1.4k indexed · 3 hit papers · h-index 22
Topics
Ferroptosis and cancer prognosis (7 papers)Micro and Nano Robotics (5 papers)Cellular Mechanics and Interactions (5 papers)

In The Last Decade

Qingjia Chi

63 papers receiving 1.4k citations

Hit Papers

Lactylome Analysis Unveils Lactylation‐Dependent Mechanis...202420262025202420242025255075

Peers

Qingjia Chi
Comparison fields: 5 of 129
  • Molecular Biology 652
  • Biomedical Engineering 254
  • Cancer Research 228
  • Rheumatology 125
  • Immunology 116
Replace Rui Wu with:
Rui Wu China
Mei Dong China
Meidong Liu China
Kaori Yoshida Japan
Haotian Chen China
Yuan He China
Yi Xu China
Toshihiko Hayashi Japan
Deshan Li China
Hui Zhao China
Qingjia Chi relative to Rui Wu China Rui Wu's profile →
Citations per field
00.5×1.5×
Rui Wu · 1×
Citations per year

Countries citing papers authored by Qingjia Chi

Since Specialization
Citations

This map shows the geographic impact of Qingjia Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjia Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjia Chi more than expected).

Fields of papers citing papers by Qingjia Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingjia Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjia Chi. The network helps show where Qingjia Chi may publish in the future.

Co-authorship network of co-authors of Qingjia Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Qingjia Chi. A scholar is included among the top collaborators of Qingjia Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingjia Chi. Qingjia Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 7
4
Lumican promotes calcific aortic valve disease through H3 histone lactylationbreakdown →
62
5 3
6 13
7 4
8 1
9 30
10 11
11 1
12 10
13 9
14 52
15 66
16 69
17 3
18 26
19 17
20 24

About Qingjia Chi

Qingjia Chi is a scholar working on Cancer Research, Nephrology and Applied Microbiology and Biotechnology, having authored 66 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Micro and Nano Robotics (5 papers) and Cellular Mechanics and Interactions (5 papers). The work is most often cited by research in Cancer Research (228 citations), Condensed Matter Physics (110 citations) and Molecular Biology (652 citations). Qingjia Chi has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Chunli Wang, Kang Xu, Guixue Wang, Li Yang, Jiahuan Jiang, Nianguo Dong, Zichang Yang, Kang Xu, Yan Gao and Yongqiang Sha. Their work appears in journals such as Biomaterials, Food Chemistry and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026